Home
Conditions
Neurocutaneous Syndromes

Clinical trial condition

Neurocutaneous Syndromes

Explore clinical trials studying Neurocutaneous Syndromes. Study availability and eligibility vary by location and protocol.

346 public trials 63 recruiting studies

Refine in advanced search Browse all conditions

Neurocutaneous Syndromes trial results

Not Yet Recruiting

Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients With Neurofibromatosis Type II

NCT07131722

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +26 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Safety, Tolerability, and Pharmacokinetics of SVG103 (Paxalisib) in Focal Cortical Dysplasia Type II (FCD-II), Tuberous Sclerosis Complex (TSC) or Hemimegalencephaly (HME)

NCT07287202

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Craniofacial Abnormalities, +19 more
Locations: Austin Hospital Heidelberg, Victoria, Australia

The Alfred Melbourne, Victoria, Australia

View Trial Details

Not Yet Recruiting

iCanCope With NF: Innovating an Efficacious Digital Self-management and Transitional Care Program for Adolescents With Neurofibromatosis

NCT07077408

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Follow-up Study to Evaluate the Safety and Efficacy of FCN-159 in Pediatric Participants With Neurofibromatosis Type 1

NCT07024394

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +18 more
Locations: Shanghai Ninth People's Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Low-dose Selumetinib for the Treatment of Plexiform Neurofibromas in Chinese Children

NCT06763315

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +17 more
Locations: West China Hospital of Sichuan University Chengdu, Sichuan, China

View Trial Details

Not Yet Recruiting

Clinical Study on the Treatment of Type I Neurofibromatosis With Smeitinib Hydrosulfate Capsule

NCT06620354

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

The Clinical Study of the Treatment of Patients With Type I Neurofibromatosis With Smetinib Hydrosulfate Capsule

NCT06621082

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

The Neurofibromatosis-associated Tumor Biobank

NCT03359304

Conditions: Bone Diseases, Bone Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations: Not specified

View Trial Details

Completed

Burosumab for CSHS

NCT03993821

Conditions: Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations: Children's National Hospital Washington D.C., District of Columbia, United States

View Trial Details

Completed

Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1

NCT02211768

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosarcoma, Genetic Diseases, Inborn, +22 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Neurocutaneous Syndromes

Neurocutaneous Syndromes trial results

Related conditions